PHI with Ulcerative rectosigmoiditis
How does this condition affect your private health insurance?
Rectosigmoiditis ulcerosa is a chronic inflammatory bowel disease, a localized form of ulcerative colitis, affecting the rectum and sigmoid colon. It's characterized by inflammation of the inner lining, leading to symptoms like bloody diarrhea, abdominal pain, tenesmus, and urgency. The inflammation can cause ulcerations, bleeding, and pus. It is believed to have an autoimmune component, often triggered by environmental factors in genetically predisposed individuals. The course is typically relapsing-remitting, meaning periods of active disease are interspersed with periods of remission. Management focuses on reducing inflammation and controlling symptoms.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to a few months
Duration of Illness (Lifetime)
Chronic, lifelong with periods of remission and flare-ups
Cost of Treatment (Initial)
Moderate to high (diagnosis, medication, potential hospitalization)
Cost of Treatment (Lifetime)
High (ongoing medication, regular specialist visits, endoscopies, potential hospitalizations, possible surgery)
Mortality Rate
Low directly from the condition, but increased with severe complications like toxic megacolon or colorectal cancer.
Risk of Secondary Damages
Moderate to high (anemia, malnutrition, strictures, toxic megacolon, increased risk of colorectal cancer, extra-intestinal manifestations like arthritis, skin or eye conditions, psychological impact).
Probability of Full Recovery
Very low (chronic condition, remission is possible but recurrence is common; not typically curable without colectomy).
Underlying Disease Risk
Low for direct causation; however, there is an association with other autoimmune conditions, and genetic predispositions are recognized.